All of the people in Texas who were being monitored for symptoms of Ebola have now passed the 21-day caution period. Getting some good news about Ebola stuff feels good. Finally.
There were 177 people who had contact with either Thomas Eric Duncan, the Liberian national who was the first one diagnosed in the U.S., and the two Dallas nurses who treated him, Nina Pham and Amber Vinson. State officials have said that none of those people have contracted Ebola.
The many people who were monitored included other health care workers, people who lived in the same households as the patients and any other known people in the community who could have had contact.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
“I think it is a reinforcement of the basics of what we know about this disease,” said Health and Human Services Secretary Sylvia Burwell.
Other news:
Sierra Leone journalist detained after criticizing President Ernest Bai Koroma – The radio host, David Tam-Baryoh, was arrested on Monday following a broadcast of his weekly program “Monologue” after he interviewed an opposition spokesman who criticized the president’s response to the Ebola crisis and his supposed interest in seeking a third term in office.
The status of orphans who’ve lost parents to Ebola in Sierra Leone – Children who have lost parents and other loved ones to the virus must now not only figure out how to feed themselves and care for their siblings, but how to avoid getting the virus themselves without caregivers.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Experimental drugs get the OK for use in West Africa – Even though trials for experimental drugs wouldn’t be standard in the U.S., the World Health Organization has says drugs should not be withheld in the most affected countries.
